ChemicalBook > Product Catalog >Analytical Chemistry >Standard >Pharmaceutical Impurity Reference Standards >2-Chloro-N-(2,5-dimethylphenyl)acetamide

2-Chloro-N-(2,5-dimethylphenyl)acetamide

Request For Quotation
2-Chloro-N-(2,5-dimethylphenyl)acetamide Suppliers list
Company Name: J & K SCIENTIFIC LTD.  
Tel: 18210857532 18210857532
Email: jkinfo@jkchemical.com
Company Name: Chemsky（shanghai）International Co.,Ltd.  
Tel: 021-50135380
Email: shchemsky@sina.com
Company Name: Quality Control Solutions Ltd.  
Tel: 0755-66853366 13670046396
Email: orders@qcsrm.com
Company Name: Mashilabs (Shanghai) Co.,Ltd.  
Tel: 19916721580
Email: mafarm@126.com
Company Name: Jiangsu Aikon Biopharmaceutical R&D co.,Ltd.  
Tel: 025-66028182 17714375163
Email: yftan@aikonchem.com

2-Chloro-N-(2,5-dimethylphenyl)acetamide manufacturers
2-Chloro-N-(2,5-dimethylphenyl)acetamide Basic information
Product Name:2-Chloro-N-(2,5-dimethylphenyl)acetamide
Synonyms:JR-8651, 2-Chloro-N-(2,5-dimethylphenyl)acetamide, 97%;Lidocaine impurity 22/2-Chloro-N-(2,5-dimethylphenyl)acetamide;Acetamide, 2-chloro-N-(2,5-dimethylphenyl)-;Lidocaine-015;Lidocaine Impurity 18;ART-CHEM-BB B015632;CHEMBRDG-BB 3015632;AKOS B015632
CAS:5177-35-5
MF:C10H12ClNO
MW:197.66
EINECS:
Product Categories:
Mol File:5177-35-5.mol
2-Chloro-N-(2,5-dimethylphenyl)acetamide Structure
2-Chloro-N-(2,5-dimethylphenyl)acetamide Chemical Properties
Melting point 151 °C
Boiling point 326.8±30.0 °C(Predicted)
density 1.187±0.06 g/cm3(Predicted)
solubility DCM, Methanol
form Solid
pka12.91±0.70(Predicted)
color Off-White
Safety Information
Hazard Codes Xi
HazardClass IRRITANT
MSDS Information
2-Chloro-N-(2,5-dimethylphenyl)acetamide Usage And Synthesis
UsesN-(Chloroacetyl)-2,5-dimethylaniline is an intermediate in the synthesis of impurities of Lidocaine (L397800), an anesthetic local agent and antiarrythmic class IB agent.
2-Chloro-N-(2,5-dimethylphenyl)acetamide Preparation Products And Raw materials
Tag:2-Chloro-N-(2,5-dimethylphenyl)acetamide(5177-35-5) Related Product Information
Chloro-N-(2,4-dimethylphenyl)acetamide N-Methyl-N-((3S,4S)-4-Methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyriMidin-4-aMine Tofacitinib Impurity 2 Tofacitinib Impurity 45 Tofacitinib Related Compound (3S,4S)-1-benzyl-N,4-diMethylpiperidin-3-aMine N-(2,6-dimethylphenyl)-2-((2,6-dimethylphenyl)amino)acetamide 3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI) butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate Tofacitinib Impurity N-methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine 3-((3S,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanenitrile 3-((3R,4R)-4-Methyl-3-(Methyl(7H-pyrrolo[2,3-d]pyriMidin-4-yl)aMino)piperidin-1-yl)-3-oxopropanaMide 1-Piperidinepropanoic acid, 4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-β-oxo-, ethyl ester, (3R,4R)- 7H-Pyrrolo[2,3-d]pyriMidin-4-aMine, N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-7-[(4-Met hylphenyl)sulfonyl]- 6,7-Dihydro-N-methyl-N-[(3R,4R)-4-methyl-3-piperidinyl]-5H-pyrrolo[2,3-d]pyrimidin-4-amine Tofacitinib Impurity 36 Tofacitinib Impurity